Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 358.8
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Data is available to registered users only
Target Price
Buy
Sell